Why PRP for Ovarian Reserve? The Science and Medical Next Steps

Platelet‐rich plasma (PRP) therapy has emerged in recent years as a promising adjunct for women with diminished ovarian reserve. By harnessing the body's own growth factors, PRP for ovarian reserve aims to improve ovarian function, support follicle development, and potentially restore fertility in select patients. Below, we'll explore what PRP is, the science behind its use in the ovary, published clinical evidence, potential risks, and practical next steps for women considering this treatment.

What Is PRP—and How Might It Help Ovarian Reserve?

PRP is an autologous concentration of platelets suspended in a small volume of plasma. When activated, these platelets release growth factors and cytokines that can:

• Promote angiogenesis (new blood vessel formation)
• Stimulate cell proliferation and differentiation
• Enhance tissue repair and regeneration

In orthopedics and dermatology, PRP has been used for tendon injuries and skin rejuvenation for over a decade. Applying PRP to the ovary is a newer concept, first described in small human studies in the mid-2010s. The theory is that PRP's growth factors may reinvigorate the ovarian microenvironment, potentially awakening dormant follicles or improving the health of existing ones.

The Science Behind PRP for Ovarian Reserve

1. Growth factors and cytokines

   • Platelet-derived growth factor (PDGF)
   • Vascular endothelial growth factor (VEGF)
   • Epidermal growth factor (EGF)
   • Transforming growth factor-β (TGF-β)

   These molecules support tissue remodeling, blood vessel growth, and cellular signaling—key processes for healthy follicle maturation.

2. Ovarian niche modulation

   • PRP may reduce local inflammation and oxidative stress, creating a more favorable environment for follicles.
   • Improved blood flow could enhance delivery of hormones and nutrients.

3. Stem cell activation

   • Preliminary animal studies suggest PRP can activate ovarian stem‐like cells, which may contribute to folliculogenesis (formation of new follicles).

4. Hormonal changes

   • Some reports note modest increases in anti-Müllerian hormone (AMH) and decreases in follicle-stimulating hormone (FSH) after PRP injection, indicating potential improvement in ovarian reserve markers.

Published Clinical Evidence

While large, randomized trials are still pending, early human studies and case series offer cautious optimism:

• Journal of Ovarian Research (2019): In 30 women with low ovarian reserve, intraovarian PRP was associated with improved antral follicle count in 60% of participants and a rise in AMH levels in over half
• Reproductive Biology and Endocrinology (2020): A small case series reported spontaneous pregnancies in 5 of 12 women after PRP injections combined with minimal stimulation IVF cycles
• Endocrinological Investigation (2021): Improvements in menstrual regularity and a decrease in menopausal symptoms were noted in perimenopausal women who underwent PRP treatment

Key takeaways from these studies:

• PRP for ovarian reserve appears to be safe when prepared and administered under sterile conditions by experienced physicians.
• Success rates vary widely, likely reflecting differences in patient age, baseline ovarian reserve, PRP preparation methods, and injection protocols.
• Long-term data on sustained ovarian function and live birth rates are still very limited.

Who Might Be a Candidate?

PRP for ovarian reserve is still considered experimental in most fertility centers. Potential candidates include women who:

• Are under age 45 with diminished ovarian reserve (low AMH, high FSH, low antral follicle count)
• Have had one or more failed IVF cycles with few or poor-quality eggs
• Prefer to avoid donor eggs but understand this is not a guaranteed fertility solution
• Are motivated to pursue innovative approaches under the guidance of a reproductive endocrinologist

It's not typically recommended for women with complete ovarian failure (zero follicles on ultrasound) or untreated active pelvic infection. A comprehensive fertility evaluation—hormone testing, pelvic ultrasound, and medical history review—is essential before considering PRP.

Potential Risks and Considerations

PRP uses your own blood, so the risk of allergic reaction or disease transmission is negligible. However, other factors to weigh include:

• Infection risk at the injection site (minimized by sterile technique)
• Ovarian pain, cramping, or mild discomfort after the procedure
• Cost—PRP for ovarian reserve can range from $2,000 to $5,000 per treatment, often not covered by insurance
• Uncertain efficacy—success is not guaranteed, and repeat treatments may be advised

Open communication with your physician about goals, realistic expectations, and potential alternatives (like donor eggs or adoption) is critical.

Medical Next Steps

If you're exploring PRP for ovarian reserve, consider the following pathway:

1. Initial fertility assessment

   • Hormone panel (AMH, FSH, estradiol)
   • Transvaginal ultrasound for antral follicle count
   • Review of medical and reproductive history

2. Discuss standard treatments

   • IVF with your own eggs (stimulation protocols)
   • Donor eggs, if appropriate
   • Lifestyle optimization (diet, exercise, stress management)

3. Evaluate experimental options

   • Inquire about PRP protocols at reputable fertility centers
   • Ask about participation in clinical trials or registries to track outcomes
   • Review published data and facility success rates

4. Pre-procedure preparation

   • Complete infectious disease screening
   • Optimize hemoglobin and platelet counts
   • Abstain from anti-inflammatories that can reduce platelet function

5. PRP procedure and follow-up

   • Blood draw, centrifugation, and ovarian injection under ultrasound guidance
   • Monitor hormone levels and follicle growth in the weeks following
   • Plan for an IVF cycle or natural conception attempt once follicles develop

Throughout this journey, maintaining open dialogue with a reproductive endocrinologist and your primary care doctor is essential.

When to Seek Further Evaluation

Diminished ovarian reserve can be a sign of Primary Ovarian Insufficiency (POI) in some women. If you experience irregular or missed periods, hot flashes, or unexplained infertility before age 40, you may benefit from a comprehensive evaluation to understand whether POI is affecting your fertility and overall hormonal health.

Conclusion and Final Advice

PRP for ovarian reserve represents an exciting frontier in reproductive medicine. While early studies suggest safety and possible benefits, robust, long-term outcomes are still under investigation. If you're considering PRP:

• Seek care at a reputable fertility clinic with experience in ovarian PRP
• Understand the experimental nature of the treatment and associated costs
• Explore all fertility options and maintain realistic expectations

Always speak to a doctor about any life-threatening or serious health concerns, including unexpected symptoms after any medical procedure. A tailored treatment plan, informed by your medical history and test results, is the best path forward in your fertility journey.